David Tate, MD
Radiation Oncology · Saint Helena, CANPI 1336123504
Payments from drug & device makers
Across 101 payments — averaging $131.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Products Limited$5K
- Janssen Research & Development, LLC$4K
- Pharmacyclics LLC, An Abbvie Company$2K
- AstraZeneca$495
- Johnson & Johnson$293
- Merck$282
- plus $2K from 32 others
What the payments were for
- Food & beverage$3,175100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Products Limited | 1 | $5,000 |
| Janssen Research & Development, LLC | 1 | $3,553 |
| Pharmacyclics LLC, An Abbvie Company | 10 | $1,600 |
| AstraZeneca | 12 | $495 |
| Johnson & Johnson(2 entities) | 7 | $293 |
| Merck | 10 | $282 |
| Reflexion Medical, Inc. | 4 | $228 |
| Teleflex LLC | 2 | $197 |
| Zap Surgical Systems, Inc. | 1 | $154 |
| Abbott | 1 | $147 |
| Pfizer | 4 | $116 |
| Novartis | 4 | $108 |
| Daiichi Sankyo Inc. | 4 | $106 |
| AbbVie | 5 | $103 |
| Regeneron Healthcare Solutions, Inc. | 3 | $102 |
| Bayer | 4 | $98 |
| Corcept Therapeutics | 1 | $89 |
| Genentech USA, Inc. | 2 | $55 |
| Amgen | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Eisai Inc. | 2 | $45 |
| Myriad Genetic Laboratories, Inc. | 2 | $42 |
| Syndax Pharmaceuticals, Inc. | 1 | $34 |
| Taiho Oncology, Inc. | 1 | $32 |
| Foundation Medicine, Inc. | 1 | $29 |
| Incyte Corporation | 1 | $29 |
| Siemens Medical Solutions USA, Inc. | 1 | $28 |
| Myovant Sciences Inc. | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Progenics Pharmaceuticals, Inc. | 1 | $24 |
| Bristol Myers Squibb | 1 | $23 |
| Invivyd Inc | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Geron Corporation | 1 | $20 |
| Varian Medical Systems, Inc. | 1 | $20 |
| Caris MPI, Inc. | 1 | $18 |
| Bard Peripheral Vascular, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,328 in reported general payments places this provider in the 85th percentile of 627 radiation oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 16 | $305 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Saint Helena
- Loren Mellla Jolla$10M
- Hyun KimDuarte$6M
- Megan DalyOrange$4.5M
- Percy LeeIrvine$2.4M
- Felix FengSan Francisco$1.8M
- Jeffrey WongDuarte$1.7M
- Arta MonjazebSacramento$1.5M
- Rakesh PatelLos Gatos$1.3M
- Maximilian DiehnStanford$1.2M
- Rizwan NuraniApple Valley$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.